Synthesis, antibacterial activity and docking of 14-membered 9-O-(3-arylalkyl) oxime 11,12-cyclic carbonate ketolides

Jian Hua Liang; Kun An; Wei Lv; Mark Cushman; He Wang; Ying Chun Xu

doi:10.1016/j.ejmech.2012.10.054

Synthesis, antibacterial activity and docking of 14-membered 9-O-(3-arylalkyl) oxime 11,12-cyclic carbonate ketolides

Jian Hua Liang^*, Kun An, Wei Lv, Mark Cushman, He Wang, Ying Chun Xu

^*此作品的通讯作者

化学与化工学院

科研成果: 期刊稿件 › 文章 › 同行评审

15 引用（Scopus）

摘要

A series of 9-O-(3-aryl-2-propargyl)oxime ketolides 8 was synthesized and evaluated for in vitro antibacterial activity. Among 8, 8b-8d, and 8h-8l displayed dramatically improved potency against inducibly MLS _B-resistant and efflux-resistant pathogens as compared to clarithromycin and azithromycin. Especially, 8i (Ar4-isoquinolyl) possessed an MIC of 0.064 μg/mL against constitutively MLS_B-resistant Streptococcus pneumoniae, and MICs of 0.032-0.064 μg/mL against methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus hominis. The analog 10 with a propyl linker was less effective than both the corresponding 8 and 9 containing propynyl and propenyl linkers. A docking study was performed to gain insight into the binding mode of series 8 and 9 and to rationalize the disparity found in the SAR of 8 and 9.

源语言	英语
页（从-至）	54-63
页数	10
期刊	European Journal of Medicinal Chemistry
卷	59
DOI	https://doi.org/10.1016/j.ejmech.2012.10.054
出版状态	已出版 - 1月 2013

访问文件

10.1016/j.ejmech.2012.10.054

其它文件与链接

链接到 Scopus 的出版物

引用此

@article{5ed8ccb52426451798054a36223c2a50,

title = "Synthesis, antibacterial activity and docking of 14-membered 9-O-(3-arylalkyl) oxime 11,12-cyclic carbonate ketolides",

abstract = "A series of 9-O-(3-aryl-2-propargyl)oxime ketolides 8 was synthesized and evaluated for in vitro antibacterial activity. Among 8, 8b-8d, and 8h-8l displayed dramatically improved potency against inducibly MLS B-resistant and efflux-resistant pathogens as compared to clarithromycin and azithromycin. Especially, 8i (Ar4-isoquinolyl) possessed an MIC of 0.064 μg/mL against constitutively MLSB-resistant Streptococcus pneumoniae, and MICs of 0.032-0.064 μg/mL against methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus hominis. The analog 10 with a propyl linker was less effective than both the corresponding 8 and 9 containing propynyl and propenyl linkers. A docking study was performed to gain insight into the binding mode of series 8 and 9 and to rationalize the disparity found in the SAR of 8 and 9.",

keywords = "Antibacterial activity, Erythromycin, Ketolide, Macrolide, Multi-drug resistance, Oxime",

author = "Liang, {Jian Hua} and Kun An and Wei Lv and Mark Cushman and He Wang and Xu, {Ying Chun}",

year = "2013",

month = jan,

doi = "10.1016/j.ejmech.2012.10.054",

language = "English",

volume = "59",

pages = "54--63",

journal = "European Journal of Medicinal Chemistry",

issn = "0223-5234",

publisher = "Elsevier Masson s.r.l.",

}

TY - JOUR

T1 - Synthesis, antibacterial activity and docking of 14-membered 9-O-(3-arylalkyl) oxime 11,12-cyclic carbonate ketolides

AU - Liang, Jian Hua

AU - An, Kun

AU - Lv, Wei

AU - Cushman, Mark

AU - Wang, He

AU - Xu, Ying Chun

PY - 2013/1

Y1 - 2013/1

N2 - A series of 9-O-(3-aryl-2-propargyl)oxime ketolides 8 was synthesized and evaluated for in vitro antibacterial activity. Among 8, 8b-8d, and 8h-8l displayed dramatically improved potency against inducibly MLS B-resistant and efflux-resistant pathogens as compared to clarithromycin and azithromycin. Especially, 8i (Ar4-isoquinolyl) possessed an MIC of 0.064 μg/mL against constitutively MLSB-resistant Streptococcus pneumoniae, and MICs of 0.032-0.064 μg/mL against methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus hominis. The analog 10 with a propyl linker was less effective than both the corresponding 8 and 9 containing propynyl and propenyl linkers. A docking study was performed to gain insight into the binding mode of series 8 and 9 and to rationalize the disparity found in the SAR of 8 and 9.

AB - A series of 9-O-(3-aryl-2-propargyl)oxime ketolides 8 was synthesized and evaluated for in vitro antibacterial activity. Among 8, 8b-8d, and 8h-8l displayed dramatically improved potency against inducibly MLS B-resistant and efflux-resistant pathogens as compared to clarithromycin and azithromycin. Especially, 8i (Ar4-isoquinolyl) possessed an MIC of 0.064 μg/mL against constitutively MLSB-resistant Streptococcus pneumoniae, and MICs of 0.032-0.064 μg/mL against methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus hominis. The analog 10 with a propyl linker was less effective than both the corresponding 8 and 9 containing propynyl and propenyl linkers. A docking study was performed to gain insight into the binding mode of series 8 and 9 and to rationalize the disparity found in the SAR of 8 and 9.

KW - Antibacterial activity

KW - Erythromycin

KW - Ketolide

KW - Macrolide

KW - Multi-drug resistance

KW - Oxime

UR - http://www.scopus.com/inward/record.url?scp=84870217771&partnerID=8YFLogxK

U2 - 10.1016/j.ejmech.2012.10.054

DO - 10.1016/j.ejmech.2012.10.054

M3 - Article

C2 - 23202851

AN - SCOPUS:84870217771

SN - 0223-5234

VL - 59

SP - 54

EP - 63

JO - European Journal of Medicinal Chemistry

JF - European Journal of Medicinal Chemistry

ER -

Synthesis, antibacterial activity and docking of 14-membered 9-O-(3-arylalkyl) oxime 11,12-cyclic carbonate ketolides

摘要

访问文件

其它文件与链接

指纹

引用此